Infection Prevention and Control

Herald Meetings welcomes participants from all over the world to attend "2^nd International Conference on Infection Prevention and Control” to be held from August 10-11, 2026 in NH Roma Villa Carpegna, Rome, Italy. We are delighted to invite speakers, students, delegates, sponsors, exhibitors and media partners from all over the world to attend the conference.

The theme of the conference is “Infectious Diseases Prevention, Control and Cure”.

Infection Control 2026 will provide a platform for a wide range of professionals, including Infectious Diseases Specialists, Researchers, Scientists, Healthcare Professionals, Clinicians, Students, Business Professionals, Academicians and Industry Leaders. This event will provide an opportunity for attendees from Infectious Diseases Associations and Societies, Medical Device Manufacturing Companies, Drug Manufacturing Companies, Medical Colleges and Pharmaceutical Companies to exchange experiences and share research findings on all aspects of infection prevention and control. It will also offer an interdisciplinary forum for researchers, practitioners, and educators to present and discuss the latest innovations, trends, challenges, and solutions in the field of infection prevention and control.

Infection control is required to prevent the transmission of communicable diseases in all healthcare settings. It requires a basic understanding of epidemiology of diseases, risk factors that increase patient susceptibility to infections, and the practices, procedures, and treatments that may lead to infections. The risk of acquiring a healthcare-associated infection is influenced by the mode of transmission of the infectious agent (e.g., CRE, CDI, MRSA, SSI, etc.), the type of patient-care activity or procedure being performed, and the patient's underlying immune defenses.

When we look at the worldwide deaths due to Infectious Diseases the conference get significance on some diseases like Tetanus (50,000), measles (150,000), Malaria (700,000), hepatitis b (1 million), diarrhoea (800,000), tuberculosis (1.5 million), HIV/AIDS (1 million) and respiratory Infections (4 million).

IPC 2026 will provide a unique forum for participants to exchange knowledge and experience in the prevention of healthcare-associated infections and control of antimicrobial resistance around the world.

Why to attend?

• It’s a great chance to connect with other professionals and learn from their experiences.
• You will be updated on the latest research and best practices in infection prevention.
• You can participate in workshops to learn new skills or tools to improve infection control.
• You can present your own work or ideas and get feedback from others.
• The information you learn can help prevent infections and improve patient care in your workplace.
• You'll learn about international guidelines and how infection control is handled worldwide.

Target Audience

• Infectious Diseases Specialists
• Infectious Diseases Experts
• Infection Prevention and Infection Control Specialists
• Microbiologists
• Virologists
• Bacteriologists
• Pathologists
• Parasitologists
• Mycologists
• Immunologists
• Epidemiologists
• Allergists
• Dermatologists
• Neurologists
• Pediatricians
• Clinical Investigators
• Physicians
• Pharmacists
• Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
• Infectious Diseases Researchers, Scientists, Faculties, Students
• Research Associates
• Academic and Health Care Professionals
• Infectious Diseases Associations and Societies
• Health Care Associations and Societies
• Medical Colleges and Training Institutes
• Medical, Pharmacy Companies and Industries
• Medical Devices and Drug Manufacturing Companies and Industries
• Laboratory Technicians and Diagnostic Companies
• Business Entrepreneurs and Industrialists